The Xeloda market, defined as the global market for capecitabine, an oral chemotherapy medication, is highly relevant in the pharmaceutical industry. As we delve into the Xeloda market size, growth outlook, market forecast, and industry expansion, it becomes evident that this market is poised for significant growth. The current Xeloda market size is approximately $1.4 billion, with a projected growth forecast of 4-6% CAGR from 2026 to 2033, driven by increasing cancer incidence rates, advancements in medical technology, and an aging population. Key forces shaping the industry include technology shifts towards personalized medicine, regulations governing drug pricing and approval, and competitive intensity among pharmaceutical companies.